Effect of Matrix Metallopeptidase 13 on the Function of Mouse Bone Marrow-derived Dendritic Cells

Background: Dendritic cells are professional antigen-presenting cells found in an immature state in epithelia and interstitial space, where they capture antigens such as pathogens or damaged tissue. Matrix metallopeptidase 13 (MMP- 13), a member of the collagenase subfamily, is involved in many diff...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 130; no. 6; pp. 717 - 721
Main Authors Li, Xiao-Dong, Zhang, Xin-Rui, Li, Zhi-Hao, Yang, Yang, Zhang, Duo, Zheng, Heng, Dong, Shu-Ying, Chen, Juan, Zeng, Xian-Dong
Format Journal Article
LanguageEnglish
Published China Medknow Publications and Media Pvt. Ltd 20.03.2017
Lippincott Williams & Wilkins Ovid Technologies
Department of Dermatology, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning 110024, China%Department of Dermatology Key Laboratory of Immunodermatology, No.1 Hospital of China Medical University, Shenyang, Liaoning 110001, China%Department of Oncology, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning 110024, China
Medknow Publications & Media Pvt Ltd
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Dendritic cells are professional antigen-presenting cells found in an immature state in epithelia and interstitial space, where they capture antigens such as pathogens or damaged tissue. Matrix metallopeptidase 13 (MMP- 13), a member of the collagenase subfamily, is involved in many different cellular processes and is expressed in murine bone marrow-derived dendritic cells (DCs). The function of MMP-13 in DCs is not well understood. Here, we investigated the effect of MMP-13 on DC maturation, apoptosis, and phagocytosis. Methods: Bone marrow-derived dendritic cells were obtained fiom C57BL/6 mice. One short-interfering RNA specific for MMP- 13 was used to transfect DCs. MMP-13-silenced DCs and control DCs were prepared, and apoptosis was measured using real-time polymerase chain reaction and Western blotting. MMP-13-silenced DCs and control DCs were analyzed for surface expression of CD80 and CD86 and phagocytosis capability using flow cytometry. Results: Compared to the control DCs, MMP- 13-silenced DCs increased expression of anti-apoptosis-related genes, BAGl (control group vs. MMP-13-silenced group: 4.08 ± 0.60 vs. 6.11 ± 0.87, P = 0.008), BCL-2 (control group vs. MMP-13-silenced group: 7.54 ± 0.76 vs. 9.54 ± 1.29, P = 0.036), and TP73 (control group vs. MMP- 13-silenced group: 4.33 ± 0.29 vs. 5.60 ±0.32, P = 0.001 ) and decreased apoptosis-related genes, CASPI (control group vs. MMP- 13-silenced group: 3.79±0.67 vs. 2.54±0.39, P - 0.019), LTBR (control group vs. MMP- 13-silenced group: 9.23 ±1.25 vs. 6.24 ± 1.15, P = 0.012), and CASP4 (control group vs. MMP-13-silenced group: 2.07 ± 0.56 vs. 0.35 ±0.35, P = 0.002). Protein levels confirmed the same expression pattern. MMP- 13-silenced groups decreased expression of CD86 on DCs; however, there was no statistical difference in CD80 surface expression. Furthermore, MMP-13-silenced groups exhibited weaker phagocytosis capability. Conclusion: These results indicate that MMP-13 inhibition dampens DC maturation, apoptosis, and phagocytosis.
Bibliography:Background: Dendritic cells are professional antigen-presenting cells found in an immature state in epithelia and interstitial space, where they capture antigens such as pathogens or damaged tissue. Matrix metallopeptidase 13 (MMP- 13), a member of the collagenase subfamily, is involved in many different cellular processes and is expressed in murine bone marrow-derived dendritic cells (DCs). The function of MMP-13 in DCs is not well understood. Here, we investigated the effect of MMP-13 on DC maturation, apoptosis, and phagocytosis. Methods: Bone marrow-derived dendritic cells were obtained fiom C57BL/6 mice. One short-interfering RNA specific for MMP- 13 was used to transfect DCs. MMP-13-silenced DCs and control DCs were prepared, and apoptosis was measured using real-time polymerase chain reaction and Western blotting. MMP-13-silenced DCs and control DCs were analyzed for surface expression of CD80 and CD86 and phagocytosis capability using flow cytometry. Results: Compared to the control DCs, MMP- 13-silenced DCs increased expression of anti-apoptosis-related genes, BAGl (control group vs. MMP-13-silenced group: 4.08 ± 0.60 vs. 6.11 ± 0.87, P = 0.008), BCL-2 (control group vs. MMP-13-silenced group: 7.54 ± 0.76 vs. 9.54 ± 1.29, P = 0.036), and TP73 (control group vs. MMP- 13-silenced group: 4.33 ± 0.29 vs. 5.60 ±0.32, P = 0.001 ) and decreased apoptosis-related genes, CASPI (control group vs. MMP- 13-silenced group: 3.79±0.67 vs. 2.54±0.39, P - 0.019), LTBR (control group vs. MMP- 13-silenced group: 9.23 ±1.25 vs. 6.24 ± 1.15, P = 0.012), and CASP4 (control group vs. MMP-13-silenced group: 2.07 ± 0.56 vs. 0.35 ±0.35, P = 0.002). Protein levels confirmed the same expression pattern. MMP- 13-silenced groups decreased expression of CD86 on DCs; however, there was no statistical difference in CD80 surface expression. Furthermore, MMP-13-silenced groups exhibited weaker phagocytosis capability. Conclusion: These results indicate that MMP-13 inhibition dampens DC maturation, apoptosis, and phagocytosis.
Apoptosis; Dendritic Cell; Matrix Metallopeptidase 13: Maturation: Phagocytosis
11-2154/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0366-6999
2542-5641
DOI:10.4103/0366-6999.201602